Global Automated Nucleic Acid Extraction Devices Market, By Type (Instruments, Kits and Consumables), Product (Fully Automated, Semi-Automated), End User (Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Academic Research Institutes) – Industry Trends and Forecast to 2030.
Automated Nucleic Acid Extraction Devices Market Analysis and Size
According to Data Bridge Market Research, the automated nucleic acid extraction devices market is expected to grow significantly in developed economies during the forecast period of 2023-2030 due to factors such as increasing adoption of superior technology for faster and better results, increasing demand for new extraction techniques, technological advancement in analytical instruments and laboratory automation, and other factors that are propelling the market forward. Furthermore, the increasing number of R&D activities will create new opportunities for the automated nucleic acid extraction devices market during the forecast period of 2023-2030.
Data Bridge Market Research analyses that the automated nucleic acid extraction devices market which is USD 4.7 billion in 2022, is expected to reach USD 11.15 billion by 2030, at a CAGR of 11.4% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Automated Nucleic Acid Extraction Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Instruments, Kits and Consumables), Product (Fully Automated, Semi-Automated), End User (Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Academic Research Institutes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
QIAGEN (Germany), F. Hoffmann-La Roche Ltd (U.S.), Analytik Jena GmbH+Co. KG (Germany), Thermo Fisher Scientific Inc. (U.S.), AccuBioMed Co., Ltd. (Taiwan), AUTOGEN INC. (U.S.), Bioneer Corporation (South Korea), Illumina, Inc. (U.S.), Tecan Trading AG (Switzerland), Merck KGaA (Germany), BD (U.S.), PerkinElmer, Inc. (U.S.), DiaSorin S.p.A (Italy)
|
|
Market Opportunities
|
|
Market Definition
Automated devices significantly reduce the time and labour required to manually extract nucleic acids from the same number of samples. They also avoid the introduction of human error that can occur during manual extraction. The automated nucleic acid extraction devices are adaptable and efficient systems for fully automated nucleic acid isolation. They are based on a unique liquid handling method and the proven principle of magnetic particle separation or smart extraction, such as the GENE PREP STAR, which is an automated plasmid DNA extractor used by many clinical and research institutes.
Automated Nucleic Acid Extraction Devices Market Dynamics
Drivers
- Increasing demand of new extraction techniques
Nucleic acid amplification has advanced at an unprecedented rate, resulting in increased sensitivity and specificity. However, to obtain satisfactory results when using this new technique, testing must go through several significant phases. Sample preparation and collection, specimen transportation and storage, sample stability, and nucleic acid extraction are all variables used in preanalytical testing. This increases the market's growth.
- Growing number of research and development activities
The extraction of nucleic acids is the first step in many research and therapeutic applications. Numerous nucleic acid samples must be extracted as a starting point for the implementation of high-throughput multiplex systems for genotyping, gene expression, and epigenetic profiling. The results of these methods have important implications for fundamental research as well as clinical diagnosis and follow-up. This contributes to market expansion.
Opportunities
- Technological advancement in analytical instruments and laboratory automation
BioMérieux's NucliSens easy MAGTM is a user-friendly automated device designed for extracting high-quality RNA and DNA. The primary goals of the development were to improve the overall design, usability, and convenience of an automated platform, particularly when compared to previous-generation instruments, as well as to improve the performance of the underlying chemistry for nucleic acid extraction.
Restraints/Challenges
- High cost
The high maintenance and service costs and the limited product acceptability will slow the market's growth rate. The lack of skilled professionals and a lack of healthcare infrastructure in developing economies will pose a challenge to the market for automated nucleic acid extraction devices.
This automated nucleic acid extraction devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the automated nucleic acid extraction devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Automated Nucleic Acid Extraction Devices Market
The COVID-19 outbreak had a positive effect on the market. Disease outbreaks such as SARS, MERS, swine flu, Ebola, and COVID-19 (current) have caused misery, fatalities, and financial losses around the world. Rapid point-of-care (POC) molecular detection of human and plant diseases is becoming increasingly important in order to control disease spread and protect human populations. Nucleic acid-based molecular diagnosis reveals disease-causing pathogens and their pathogenesis at the genomic level, which benefits patients, healthcare providers, and researchers by enabling more effective pathogen detection, disease progression tracking, and treatment planning.
Global Automated Nucleic Acid Extraction Devices Market Scope
The automated nucleic acid extraction devices market is segmented on the basis of product, type, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Instruments
- Kits
- Consumables
Product
- Fully Automated
- Semi-Automated
End User
- Hospitals
- Diagnostic Centers
- Forensic Laboratories
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
Automated Nucleic Acid Extraction Devices Market Regional Analysis/Insights
The automated nucleic acid extraction devices market is analyzed and market size insights and trends are provided by country, product, type, end-user as referenced above.
The countries covered in the automated nucleic acid extraction devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the automated nucleic acid extraction devices market due to the adoption of stringent standards for analysis along with rapid technological advancement.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the availability of advanced laboratory equipment along with growing number of research and development activities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The automated nucleic acid extraction devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for automated nucleic acid extraction devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the automated nucleic acid extraction devices market. The data is available for historic period 2011-2021.
Competitive Landscape and Automated Nucleic Acid Extraction Devices Market Share Analysis
The automated nucleic acid extraction devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to automated nucleic acid extraction devices market.
Some of the major players operating in the automated nucleic acid extraction devices market are:
- QIAGEN (Germany)
- F. Hoffmann-La Roche Ltd (U.S.)
- Analytik Jena GmbH+Co. KG (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- AccuBioMed Co., Ltd. (Taiwan)
- AUTOGEN INC. (U.S.)
- Bioneer Corporation (South Korea)
- Illumina, Inc. (U.S.)
- Tecan Trading AG (Switzerland)
- Merck KGaA (Germany)
- BD (U.S.)
- PerkinElmer, Inc. (U.S.)
- DiaSorin S.p.A (Italy)
- Diagcor Bioscience Incorporation Limited (China)
SKU-